drugset / Trial / NCT05747508
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomized, double-blind, placebo-controlled dose escalation study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary fibrosis on long term oxygen therapy.
Timeline
- Start
- 2017-12-29
- Primary completion
- 2019-11-22
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 30 ug/kg | Inhaled |
| Subject | Nitric Oxide | Other / unclassified | 45 ug/kg | Inhaled |
| Subject | Nitric Oxide | Other / unclassified | 75 ug/kg | Inhaled |